Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio 
; Baker, Glen; Dursun, Serdar M.; Santos, Rafael Guimarães dos
Fonte: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Assuntos: BIOMARCADORES, ANESTÉSICOS, ALUCINOGÊNICOS, DEPRESSÃO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, v. 273, n. 1, p. 129-155, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01460-2. Acesso em: 09 nov. 2025.APA
Rossi, G. N., Hallak, J. E. C., Baker, G., Dursun, S. M., & Santos, R. G. dos. (2023). The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, 273( 1), 129-155. doi:10.1007/s00406-022-01460-2NLM
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 1): 129-155.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1007/s00406-022-01460-2Vancouver
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 1): 129-155.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1007/s00406-022-01460-2
